Jennifer E. Cook, a Director at BridgeBio Pharma, Inc. (BBIO), divested 88,737 shares of the company's stock on June 17, 2026. The sale, executed at an average price of $66.62 per share, amounted to approximately $5.91 million.
This transaction follows other recent sales by Ms. Cook, who previously sold 1,503 shares on June 15, 2026. Additionally, Neil Kumar, another insider, has engaged in multiple share sales in early June.
Insider sales can be attributed to various personal financial considerations, such as portfolio diversification or tax planning, and do not necessarily indicate a negative view of the company's future prospects.